Back to results
US 2012/0070464 A1Published application
Monoparamunity inducers based on attenuated rabbit myxomaviruses
OwnerAnton Mayr, Barbara Mayrinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to monoparamunity inducers based on paramunizing viruses or viral components of a myxomavirus strain from rabbits with typically generalizing disease, to a method for the production thereof and to the use thereof as medicaments for the regulatory optimization of the paramunizing activities for the prophylaxis and therapy of various dysfunctions in humans and animals.
Claims20
1-48. (canceled)
A method for regulating immune cells in a human patient comprising administering to the patient an inactivated, attenuated myxomavirus or a polypeptide or protein component thereof.
Dependencies are inferred from the claim text.